Skip to Main Content

An official website of the United States government

About this Publication
Title
Dietary consumption of tea and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Pubmed ID
34511161 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Br J Nutr. 2021 Sep 13; Pages 1-6
Authors
Thomas R, Greef B, McConnachie A, Stanley B, Williams M
Affiliations
  • The Primrose Lifestyle Research Unit, Bedford Hospital, Bedford, BedfordshireMK42 9DJ, UK.
  • Department of Oncology, Addenbrookes' Hospital NHS Trust, Cambridge, CambridgeshireCB2 2QQ, UK.
  • Institute of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, Robertson Centre for Biostatistics, University Avenue, University of Glasgow, GlasgowG12 8QQ, UK.
Abstract

Tea contains polyphenols such as flavonoids, anthocyanidins, flavanols and phenolic acids which in laboratory studies have reported to promote antioxidant enzyme formation, reduces excess inflammation, slow cancer cell proliferation and promote apoptosis. Evidence from epidemiological studies on the effect of tea consumption on prostate cancer (CaP) incidence has been conflicting. We analysed data from 25 097 men within the intervention arm of the 155 000 participant Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Histologically confirmed cases of prostate cancer were reported in 3088 men (12·3 %) during the median 11·5 year follow-up. Tea consumption was assessed with a FFQ. Baseline characteristics were compared between groups using χ2 and Kruskal-Wallis tests. Cox regression models were used to assess associations between tea intake and CaP incidence. There was no statistical difference between the risk of CaP between men who never drank tea to those who drank tea at any quantity. Amongst tea drinkers, those in the highest third of consumption group had a small but significantly lower risk compared with those in the lowest third (11·2 % v. 13·2 % hazard ratio 1·16; (95 % CI 1·05, 1·29), P = 0·004). This pattern persisted with adjustments for demographics and lifestyle. In conclusion, among tea drinkers, there was a small positive association between drinking tea and a reduced risk of prostate cancer. It does not support starting to drink tea, if men previously did not, to reduce the risk. Further research is needed to establish whether tea is justified for future prospective nutritional intervention studies investigating CaP prevention.

Related CDAS Studies
Related CDAS Projects